COVID-19 Jab Manufacturer AstraZeneca Admits For First Time Shot CAN Cause Blood Clotting
Editor's Note: Right. "In very rare cases."
AstraZeneca, for the first time, admitted its experimental COVID-19 shot can cause a potentially deadly side effect.
The UK-based COVID-19 jab manufacturer acknowledged in legal documents submitted to the United Kingdom High Court that its shot “can, in very rare cases, cause TTS.”
TTS stands for thrombosis with thrombocytopenia syndrome – a medical condition characterized by blood clot formation combined with a low platelet count.
“The admittance, as per the Telegraph, could pave the way for a multi-million-pound legal payout,” WION reports.
Daily Mail reports that dozens of families allege they, or their loved ones, were “maimed or killed” by AstraZeneca’s COVID-19 injection.